Collagen production in cardiac fibroblasts during inhibition of angiotensin-converting enzyme and aminopeptidases

Journal of Hypertension

Volumn 22, Issue 1, 2004, Pages 209-216

  Lijnen, Paul J ^a,b   Petrov, Victor V ^a   Fagard, Robert H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Bestatin; Cardiac fibroblasts; Collagen production; Lisinopril

Indexed keywords

3 AMINOPROPIONITRILE; AMINOPEPTIDASE; ASCORBIC ACID; BESTATIN; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; FIBROBLAST; FLUOROMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY;

EID: 1442299089     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200401000-00031     Document Type: Article

References (45)

1. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber K. Cardiac angiotensin and myocardial fibrosis in the rat. Cardiovasc Res 1994; 28:1423-1432.
2. Sun Y, Zhang J, Zhang JQ, Ramires FJA. Local angiotensin and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension 2000; 35:1078-1084.
3. Schroter-Kermani C, Ochsner-Welpelo I, Kittelberger R. An inhibition ELISA for the quantification of collagen type I and type II in cyanogen bromide-digested tissues using fragments-directed antibodies. Immunol Invest 1990; 19:475-491.
4. Danilov SM, Chumachenko PV, Andreeva YV, Printseva OY, Lacis RV. Angiotensin converting enzyme expression in the inflammation zone of human myocardial infarction and rat model of skin injury. J Hypertens 1993; 11:S232-S233.
5. Sun Y, Weber K. Angiotensin-converting enzyme and wound healing in diverse tissues in the rat. J Lab Clin Med 1996; 127:94-101.
6. Allen RKA, Chai SY, Dunbar MS, Mendelsohn FAO. In vitro autoradiographic localization of angiotensin-converting enzyme in sarcoid lymph nodes. Chest 1986; 90:315-320.
7. Katwa LC, Ratajska A, Cleutjens JPM, Sun Y, Zhou G, Lee SJ, Weber KT. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular cells of the rat heart. Cardiovasc Res 1995; 29:57-64.
8. Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 1996; 28: 851-858.
9. Sun Y, Weber KT. Cell expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res 1996; 31:518-525.
10. Katwa LC, Campbell SE, Tyagy SC, Lee SJ, Cicilla GT, Weber KT. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997; 29:1375-1386.
11. Petrov V, Fagard R, Lijnen P. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002; 39:258-263.
12. Petrov V, Fagard R, Lijnen P. Transforming growth factor-beta1 induces angiotensin converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. J Renin Angiotensin Aldosterone Syst 2000; 1:342-352.
13. Petrov V, Fagard R, Lijnen P. Induction of various aminopeptidases in cardiac fibroblasts by transforming growth factor-beta1. J Hypertens 2003, 21 (suppl 4):S239.
14. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts. Response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26:809-820.
15. De Young MB, Giannattasio B, Scarpa A. Isolation of calcium-tolerant atrial and ventricular myocytes from adult rat heart. In: Fleischer S, Fleischer B (editors): Biomembranes. New York: Academic Press; 1989, pp. 662-676.
16. Friedland J, Silverstein EA. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976; 66:416-424.
17. Petrov V, Fagard R, Lijnen P. Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes. Am J Hypertens 2000; 13:535-539.
18. Peterkofsky B. Estimation of total collagen production by collagenase digestion. In: Haralson MA, Hassell JR (editors): Extracellular matrix. London: Oxford University Press; 1995, pp. 31-38.
19. Köhler E, Bertschin S, Woodtli T, Resink T, Erne P. Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts? J Vasc Res 1996; 33:315-326.
20. Downs TR, Wilfinger WW. Fluorimetric quantification of DNA in cells and tissue. Anal Biochem 1983; 131:538-547.
21. Hooper NM. Angiotensin converting enzyme: how reliable is the fluorimetric assay with benzoyl-Gly-His-Leu as substrate? Biochem J 1990; 270:840-841.
22. Lijnen P, Petrov V. Antagonism of the renin-angiotensin-aldosterone system and collagen metabolism in cardiac fibroblasts. Meth Find Exp Clin Pharmacol 1999; 21:215-227.
23. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83:1771-1779.
24. Sen S, Tarazi RC, Bumpus FM. Effects of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension 1980; 2:169-176.
25. Pahor M, Bernabei R, Sgadari A. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 1991; 18:148-157.
26. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial arteries. Circ Res 1991; 69:107-115.
27. Brilla CG, Matsabara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats. Hypertension 1996; 28:269-275.
28. Diez J, Laviades C. Monitoring fibrillar collagen turnover in hypertensive heart disease. Cardiovasc Res 1997; 35:202-205.
29. Panizio A, Parolo J, Hernandez M, Galindo MF, Genarruzabeitia E, Diez J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 1995; 8:815-822.
30. Yang CM, Kandaswamy V, Young D, Sen S. Changes in collagen phenotypes during progression and regression of cardiac hypertrophy. Cardiovasc Res 1997; 36:236-245.
31. Yu CM, Gallagher AM, Garfin PM, Printz MP. Prostacyclin release by rat cardiac fibroblasts. Inhibition of collagen expression. Hypertension 1997; 30:1047-1053.
32. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor-β-induced collagen synthesis: downregulation by cAMP. FASEB J 1999; 13:1774-1786.
33. 1 in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000; 32:1805-1819.
34. Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, et al. Acute angiotensin-converting enzyme inhibition increase the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 1996; 97:839-844.
35. Rousseau A, Micheaud A, Chauvet MT, Lenfant M, Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific subtrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem 1995; 270:3656-3661.
36. Azizi M, Ezan E, Nicolet L, Grognet JM, Menard J. High plasma level of N-acetyl-seryl-aspartyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition. Hypertension 1997; 30:1015-1019.
37. Rhaleb NE, Peng H, Harding P, Tayeh M, LaPointe MC, Carretero OA. Effect of N-acetyl-seryl-aspartyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. Hypertension 2001; 37:827-832.
38. Pokharel S, Rasoul S, Roks AJM, van Leuwen REW, van Luyn MJA, Deelman LE, et al. N-Acetyl-Ser-Asp-Lys-Pro inhibits phosphorylation of Smad2 in cardiac fibroblasts. Hypertension 2002; 40:155-161.
39. 1-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells. J Am Soc Nephrol 2003; 14:863-872.
40. Kubota K, Okazaki J, Louie O, Kent KC, Liu B. TGF-β stimulates collagen (I) in vascular smooth muscle cells via a short element in the proximal collagen promoter. J Surg Res 2003; 109:43-50.
41. Liu YH, Yang WP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. J Clin Invest 1997; 26:101-111.
42. Liu YH, Yang XP, Sharov VG, Sigmon DH, Sabbah HN, Carretero OA. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 1996; 27:7-13.
43. Araki M, Kanda T, Imai S, Suzuki T, Murata K, Kobayashi I. Comparative effects of losartan, captopril and enalapril on murine acute myocarditis due to encephalomyocarditis. J Cardiovasc Pharmacol 1995; 26:61-65.
44. Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. J Pharmacol Exp Ther 1999; 289:295-303.
45. Lijnen P, Petrov V, Fagard R. Cardiac renin-angiotensin-aldosterone system and myocardial collagen matrix remodeling. Curr Topics Pharmacol 2003; 7:33-67.